HF
ALBO

HRT Financial’s Albireo Pharma Inc ALBO Stock Holding History

HRT Financial’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-48,539
Closed -$939K – 3556
2022
Q3 		$939K Buy
+48,539
New +$1M 0.01% 978
2022
Q2 		– Sell
-13,239
Closed -$394K – 4016
2022
Q1 		$394K Sell
13,239
-1,645
-11% -$48.2K ﹤0.01% 2032
2021
Q4 		$346K Buy
+14,884
New +$396K ﹤0.01% 2168
2021
Q3 		– Sell
-7,236
Closed -$254K – 3932
2021
Q2 		$254K Buy
+7,236
New +$235K ﹤0.01% 2256

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

HRT Financial's ALBO Position: Q4 2022 in Review

HRT Financial sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 48,539 shares — an estimated $939K sold.

HRT Financial first reported a position in ALBO in Q2 2021 and held it in 4 quarters. The position peaked at $939K in Q3 2022. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • HRT Financial reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 48,539 Albireo Pharma Inc shares in Q4 2022, an estimated $939K.
  • HRT Financial first reported a position in Albireo Pharma Inc in Q2 2021 and held it in 4 quarters.
  • HRT Financial's Albireo Pharma Inc position peaked at $939K in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.